ID

31771

Description

Flupirtine as Oral Treatment in Multiple Sclerosis; ODM derived from: https://clinicaltrials.gov/show/NCT00623415

Link

https://clinicaltrials.gov/show/NCT00623415

Keywords

Versions (1)
  1. 9/27/18 9/27/18 -
Copyright Holder

See clinicaltrials.gov

Uploaded on

September 27, 2018

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Relapsing Remitting Multiple Sclerosis NCT00623415

English

Eligibility Relapsing Remitting Multiple Sclerosis NCT00623415

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
relapsing-remitting ms according to the revised mcdonald-criteria (2005)
Description

Multiple Sclerosis, Relapsing-Remitting

Data type

boolean

Alias
UMLS CUI [1]
C0751967
edss ≤ 4.0
Description

EDSS

Data type

boolean

Alias
UMLS CUI [1]
C0451246
stable treatment with interferon-β1b for at least 6 months
Description

Interferon beta-1b Stable

Data type

boolean

Alias
UMLS CUI [1,1]
C0244713
UMLS CUI [1,2]
C0205360
sufficient birth control (pearl-index <1)
Description

Contraceptive methods | Other Coding

Data type

boolean

Alias
UMLS CUI [1]
C0700589
UMLS CUI [2]
C3846158
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
any other ms-course than rrms
Description

Multiple Sclerosis Except Relapsing-Remitting Multiple Sclerosis

Data type

boolean

Alias
UMLS CUI [1,1]
C0026769
UMLS CUI [1,2]
C0332300
UMLS CUI [1,3]
C0751967
clinically relevant gastrointestinal disease
Description

Gastrointestinal Diseases

Data type

boolean

Alias
UMLS CUI [1]
C0017178
clinically relevant pulmonary, cardiological, infectious or cns-disease
Description

Lung disease | Heart Disease | Communicable Disease | CNS disorder

Data type

boolean

Alias
UMLS CUI [1]
C0024115
UMLS CUI [2]
C0018799
UMLS CUI [3]
C0009450
UMLS CUI [4]
C0007682
clinically relevant disease of liver or bile system, pathological value for transaminases, gamma-gt or bilirubin.
Description

Liver disease | Bile Duct Disease | Transaminases abnormal | Gamma-GT abnormal | Bilirubin abnormal

Data type

boolean

Alias
UMLS CUI [1]
C0023895
UMLS CUI [2]
C0005395
UMLS CUI [3]
C1328397
UMLS CUI [4]
C0541979
UMLS CUI [5]
C1142335
hepatitis (except uncomplicated hepatitis a with complete remission
Description

Hepatitis | Exception Hepatitis A Uncomplicated In complete remission

Data type

boolean

Alias
UMLS CUI [1]
C0019158
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0019159
UMLS CUI [2,3]
C0443334
UMLS CUI [2,4]
C0677874
clinically relevant dysfunction of kidneys (creatinine >180 µmol/l) or bone marrow (hb < 8.5 g/dl, wbc < 2.5/nl thrombocytes < 125/nl)
Description

Renal dysfunction | Creatinine measurement, serum | Bone Marrow Dysfunction | Hemoglobin measurement | White Blood Cell Count procedure | Platelet Count measurement

Data type

boolean

Alias
UMLS CUI [1]
C3279454
UMLS CUI [2]
C0201976
UMLS CUI [3,1]
C0005953
UMLS CUI [3,2]
C3887504
UMLS CUI [4]
C0518015
UMLS CUI [5]
C0023508
UMLS CUI [6]
C0032181
myasthenia gravis
Description

Myasthenia Gravis

Data type

boolean

Alias
UMLS CUI [1]
C0026896
oral anticoagulation (phenprocoumon)
Description

Oral anticoagulants | Phenprocoumon

Data type

boolean

Alias
UMLS CUI [1]
C0354604
UMLS CUI [2]
C0031444
treatment with carbamazepine or paracetamol
Description

Carbamazepine | Paracetamol

Data type

boolean

Alias
UMLS CUI [1]
C0006949
UMLS CUI [2]
C0000970
drug or alcohol abuse
Description

Substance Use Disorders

Data type

boolean

Alias
UMLS CUI [1]
C0038586
pregnancy or lactation period
Description

Pregnancy | Breast Feeding

Data type

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
treatment at any time before or during study with complete lymphoradiation, monoclonal antibodies (e.g. anti-cd4, campath 1h, natalizumab), mitoxantrone, cyclophosphamide, cyclosporin, azathioprine
Description

Lymphatic Radiation Therapy Complete | Monoclonal Antibody Therapy | Anti-CD4 Monoclonal Antibody | Campath 1H | natalizumab | Mitoxantrone | Cyclophosphamide | Cyclosporine | Azathioprine

Data type

boolean

Alias
UMLS CUI [1,1]
C0086572
UMLS CUI [1,2]
C0205197
UMLS CUI [2]
C0279694
UMLS CUI [3]
C3831519
UMLS CUI [4]
C1178562
UMLS CUI [5]
C1172734
UMLS CUI [6]
C0026259
UMLS CUI [7]
C0010583
UMLS CUI [8]
C0010592
UMLS CUI [9]
C0004482
treatment within 6 months before randomization with any other immunomodulatory substance than interferon-β1b or intravenous methylprednisolone
Description

Biological Response Modifiers | Exception Interferon beta-1b | Exception Methylprednisolone Intravenous

Data type

boolean

Alias
UMLS CUI [1]
C0005525
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0244713
UMLS CUI [3,1]
C1705847
UMLS CUI [3,2]
C0025815
UMLS CUI [3,3]
C1522726
Back to the top of the page

Similar models

Eligibility Relapsing Remitting Multiple Sclerosis NCT00623415

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Multiple Sclerosis, Relapsing-Remitting
Item
relapsing-remitting ms according to the revised mcdonald-criteria (2005)
boolean
C0751967 (UMLS CUI [1])
EDSS
Item
edss ≤ 4.0
boolean
C0451246 (UMLS CUI [1])
Interferon beta-1b Stable
Item
stable treatment with interferon-β1b for at least 6 months
boolean
C0244713 (UMLS CUI [1,1])
C0205360 (UMLS CUI [1,2])
Contraceptive methods | Other Coding
Item
sufficient birth control (pearl-index <1)
boolean
C0700589 (UMLS CUI [1])
C3846158 (UMLS CUI [2])
Item Group
C0680251 (UMLS CUI)
Multiple Sclerosis Except Relapsing-Remitting Multiple Sclerosis
Item
any other ms-course than rrms
boolean
C0026769 (UMLS CUI [1,1])
C0332300 (UMLS CUI [1,2])
C0751967 (UMLS CUI [1,3])
Gastrointestinal Diseases
Item
clinically relevant gastrointestinal disease
boolean
C0017178 (UMLS CUI [1])
Lung disease | Heart Disease | Communicable Disease | CNS disorder
Item
clinically relevant pulmonary, cardiological, infectious or cns-disease
boolean
C0024115 (UMLS CUI [1])
C0018799 (UMLS CUI [2])
C0009450 (UMLS CUI [3])
C0007682 (UMLS CUI [4])
Liver disease | Bile Duct Disease | Transaminases abnormal | Gamma-GT abnormal | Bilirubin abnormal
Item
clinically relevant disease of liver or bile system, pathological value for transaminases, gamma-gt or bilirubin.
boolean
C0023895 (UMLS CUI [1])
C0005395 (UMLS CUI [2])
C1328397 (UMLS CUI [3])
C0541979 (UMLS CUI [4])
C1142335 (UMLS CUI [5])
Hepatitis | Exception Hepatitis A Uncomplicated In complete remission
Item
hepatitis (except uncomplicated hepatitis a with complete remission
boolean
C0019158 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0019159 (UMLS CUI [2,2])
C0443334 (UMLS CUI [2,3])
C0677874 (UMLS CUI [2,4])
Renal dysfunction | Creatinine measurement, serum | Bone Marrow Dysfunction | Hemoglobin measurement | White Blood Cell Count procedure | Platelet Count measurement
Item
clinically relevant dysfunction of kidneys (creatinine >180 µmol/l) or bone marrow (hb < 8.5 g/dl, wbc < 2.5/nl thrombocytes < 125/nl)
boolean
C3279454 (UMLS CUI [1])
C0201976 (UMLS CUI [2])
C0005953 (UMLS CUI [3,1])
C3887504 (UMLS CUI [3,2])
C0518015 (UMLS CUI [4])
C0023508 (UMLS CUI [5])
C0032181 (UMLS CUI [6])
Myasthenia Gravis
Item
myasthenia gravis
boolean
C0026896 (UMLS CUI [1])
Oral anticoagulants | Phenprocoumon
Item
oral anticoagulation (phenprocoumon)
boolean
C0354604 (UMLS CUI [1])
C0031444 (UMLS CUI [2])
Carbamazepine | Paracetamol
Item
treatment with carbamazepine or paracetamol
boolean
C0006949 (UMLS CUI [1])
C0000970 (UMLS CUI [2])
Substance Use Disorders
Item
drug or alcohol abuse
boolean
C0038586 (UMLS CUI [1])
Pregnancy | Breast Feeding
Item
pregnancy or lactation period
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Lymphatic Radiation Therapy Complete | Monoclonal Antibody Therapy | Anti-CD4 Monoclonal Antibody | Campath 1H | natalizumab | Mitoxantrone | Cyclophosphamide | Cyclosporine | Azathioprine
Item
treatment at any time before or during study with complete lymphoradiation, monoclonal antibodies (e.g. anti-cd4, campath 1h, natalizumab), mitoxantrone, cyclophosphamide, cyclosporin, azathioprine
boolean
C0086572 (UMLS CUI [1,1])
C0205197 (UMLS CUI [1,2])
C0279694 (UMLS CUI [2])
C3831519 (UMLS CUI [3])
C1178562 (UMLS CUI [4])
C1172734 (UMLS CUI [5])
C0026259 (UMLS CUI [6])
C0010583 (UMLS CUI [7])
C0010592 (UMLS CUI [8])
C0004482 (UMLS CUI [9])
Biological Response Modifiers | Exception Interferon beta-1b | Exception Methylprednisolone Intravenous
Item
treatment within 6 months before randomization with any other immunomodulatory substance than interferon-β1b or intravenous methylprednisolone
boolean
C0005525 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0244713 (UMLS CUI [2,2])
C1705847 (UMLS CUI [3,1])
C0025815 (UMLS CUI [3,2])
C1522726 (UMLS CUI [3,3])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial